TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE D-

NCT07507643: A Study of Methylprednisolone in People Having Liver Surgery

Sponsor: Memorial Sloan Kettering Cancer Center · Phase: PHASE3 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 750 pts

Competing Trials Overlap

12 Active Trials

Excess Burn Exposure

$12,210,296

Rescue Site Savings

+$8,061,624

Unlock Full NCT07507643 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07507643 Rescue Dossier →